Does SOMATROPIN Cause Product packaging quantity issue? 109 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Product packaging quantity issue have been filed in association with SOMATROPIN (Nutropin AQ NuSpin 10). This represents 0.2% of all adverse event reports for SOMATROPIN.
109
Reports of Product packaging quantity issue with SOMATROPIN
0.2%
of all SOMATROPIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Product packaging quantity issue From SOMATROPIN?
Of the 109 reports, 4 (3.7%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOMATROPIN. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does SOMATROPIN Cause?
Drug dose omission by device (15,921)
Device leakage (9,113)
Device breakage (7,761)
Device mechanical issue (6,411)
Device information output issue (5,220)
Device issue (5,131)
Wrong technique in device usage process (4,746)
Injection site pain (4,009)
Poor quality device used (3,162)
Device use error (2,801)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which SOMATROPIN Alternatives Have Lower Product packaging quantity issue Risk?
SOMATROPIN vs SONIDEGIB
SOMATROPIN vs SORAFENIB
SOMATROPIN vs SORGHUM HALEPENSE POLLEN
SOMATROPIN vs SOTAGLIFLOZIN
SOMATROPIN vs SOTALOL